scispace - formally typeset
K

Kazufumi Honda

Researcher at Japan Agency for Medical Research and Development

Publications -  121
Citations -  4871

Kazufumi Honda is an academic researcher from Japan Agency for Medical Research and Development. The author has contributed to research in topics: Cancer & Pancreatic cancer. The author has an hindex of 39, co-authored 108 publications receiving 4353 citations. Previous affiliations of Kazufumi Honda include National Cancer Research Institute.

Papers
More filters
Journal ArticleDOI

Actinin-4, a Novel Actin-bundling Protein Associated with Cell Motility and Cancer Invasion

TL;DR: It is suggested that cytoplasmic actinin-4 regulates the actin cytoskeleton and increases cellular motility and that its inactivation by transfer to the nucleus abolishes the metastatic potential of human cancers.
Journal ArticleDOI

Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer.

TL;DR: Actinin-4 actively increases cell motility and promotes lymph node metastasis of colorectal cancer.
Journal ArticleDOI

Label-free Quantitative Proteomics Using Large Peptide Data Sets Generated by Nanoflow Liquid Chromatography and Mass Spectrometry

TL;DR: An integrated platform consisting of machinery and software modules that can apply vast amounts of data generated by nanoflow LC-MS to differential protein expression analyses and warrant its application to various types of experimental and translational proteomics is developed.
Journal ArticleDOI

Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.

TL;DR: TF expression may contribute to the aggressiveness of pancreatic ductal adenocarcinoma by stimulating tumor invasiveness, and that evaluation of the primary tumor for TF expression may identify patients with a poor prognosis.
Journal ArticleDOI

Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma

TL;DR: The combination of genome-wide expression and functional screening described here is a rapid and comprehensive approach that could be applied in the identification of therapeutic targets in any type of human malignancy.